Targeting Glioblastoma Stem Cells: A40s Aptamer-NIR-Dye Conjugate for Glioblastoma Visualization and Treatment
Glioblastoma (GBM) is the most aggressive and challenging brain cancer, in terms of diagnosis and therapy. The highly infiltrative glioblastoma stem cells (GSCs) are difficult to visualize and surgically remove with the current diagnostic tools, which often lead to misdiagnosis and false-positive re...
Saved in:
| Main Authors: | Alessandra Affinito, Francesco Ingenito, Sara Verde, Emanuele Musella, Birlipta Pattanayak, Danilo Fiore, Cristina Quintavalle, Aurelia Fraticelli, Martina Mascolo, Gianluca Petrillo, Claudia Pignataro, Giada De Luca, Laura Mezzanotte, Gerolama Condorelli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/6/768 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aptamer-mediated delivery of therapeutic oligonucleotides in glioblastoma
by: Giorgia Castellani, et al.
Published: (2025-10-01) -
Varieties of interactions of anti-CD133 aptamers with cell cultures from patient glioblastoma
by: Olga Antipova, et al.
Published: (2024-12-01) -
Interactions between glioblastoma and myeloid cells
by: Yuting Li, et al.
Published: (2025-06-01) -
The Role of Insulin Receptor Substrate 4 (IRS4) Protein in the Radiotherapy Response of Glioblastoma Multiforme (GBM) Cells
by: Gökhan Görgişen, et al.
Published: (2024-10-01) -
Angiogenesis in Glioblastoma—Treatment Approaches
by: Agnieszka Nowacka, et al.
Published: (2025-03-01)